Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor

Riyaad Aungraheeta(University of Bristol), Stuart J. Mundell, Mark Butler(University of Bristol), Alexandra E. Conibear(Gomal University), Sven Nylander(AstraZeneca (Sweden)), Eamonn Kelly(University of Bristol), Andrew Mumford(University of Bristol)
Blood
October 1, 2016
Cited by 93


Related Papers